Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors
Jumpei Aida, Makoto Fushimi, Tomokazu Kusumoto, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 20, pp. 9205-9217
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
Hui Deng, Weimin Li
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 4, pp. 582-602
Open Access | Times Cited: 139
High-Throughput Screening for the Discovery of Enzyme Inhibitors
Matthew D. Lloyd
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 19, pp. 10742-10772
Open Access | Times Cited: 67
2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics
Gaurav Bedse, Mathew N. Hill, Sachin Patel
Biological Psychiatry (2020) Vol. 88, Iss. 7, pp. 520-530
Open Access | Times Cited: 54
Endocannabinoid-Based Therapies
Daniele Piomelli, Alex Mabou Tagne
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 483-507
Open Access | Times Cited: 52
Inhibitors of lipogenic enzymes as a potential therapy against cancer
Nicolás Montesdeoca, M. Allué López, Xavier Ariza, et al.
The FASEB Journal (2020) Vol. 34, Iss. 9, pp. 11355-11381
Open Access | Times Cited: 47
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence
Ming Jiang, Mirjam Huizenga, Jonah L. Wirt, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Identification of a Possible Endocannabinoid-Mediated Mechanism of Action of Cetylated Fatty Acids
Giulia Bononi, Carlotta Granchi, Tiziano Tuccinardi, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 363-363
Open Access
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Carlotta Granchi, Giulia Bononi, Rebecca Ferrisi, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112857-112857
Open Access | Times Cited: 34
Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety
Shuhei Ikeda, Hideyuki Sugiyama, Hidekazu Tokuhara, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 11014-11044
Open Access | Times Cited: 28
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Anca Zanfirescu, Anca Ungurianu, Dragoș Paul Mihai, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5668-5668
Open Access | Times Cited: 27
Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging
Yingfang He, Matthias Schild, Uwe Grether, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2191-2207
Closed Access | Times Cited: 21
Radiolabelling small and biomolecules for tracking and monitoring
Martin R. Edelmann
RSC Advances (2022) Vol. 12, Iss. 50, pp. 32383-32400
Open Access | Times Cited: 20
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives
Giulia Bononi, Miriana Di Stefano, Giulio Poli, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7118-7140
Open Access | Times Cited: 19
Steatosis in metabolic diseases: A focus on lipolysis and lipophagy
Xingtao Zhao, Felix Kwame Amevor, Zhifu Cui, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114311-114311
Open Access | Times Cited: 12
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
Giulia Bononi, Giulio Poli, Flavio Rizzolio, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 31, Iss. 2, pp. 153-168
Closed Access | Times Cited: 31
Discovery of a novel class of reversible monoacylglycerol lipase inhibitors for potential treatment of depression
Qingjing Hao, Junwei Shi, Zhilan Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116285-116285
Closed Access | Times Cited: 3
Structure–Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors
Ming Jiang, Mirjam Huizenga, Florian Mohr, et al.
Journal of Medicinal Chemistry (2024)
Open Access | Times Cited: 3
Structure-Guided Discovery of cis-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors
Bernd Kuhn, Martin Ritter, Benoit Hornsperger, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Design, Synthesis, and Evaluation of (4R)-1-{3-[2-(18F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]T-401) as a Novel Positron-Emission Tomography Imaging Agent for Monoacylglycerol Lipase
Yasushi Hattori, Kazunobu Aoyama, Jun Maeda, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 5, pp. 2362-2375
Closed Access | Times Cited: 29
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor
Ryan M. Wyatt, Ian Fraser, Natalie Welty, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 372, Iss. 3, pp. 339-353
Open Access | Times Cited: 23
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors
Miriana Di Stefano, Samuele Masoni, Giulia Bononi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115916-115916
Open Access | Times Cited: 7
Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs
Hong-Qing Zhao, Yang Liu, Na Cai, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2143-2167
Open Access | Times Cited: 2
Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications
Natasha L. Grimsey, Juha R. Savinainen, Bala Attili, et al.
Drug Discovery Today (2019) Vol. 25, Iss. 2, pp. 330-343
Closed Access | Times Cited: 20
Discovery of Aryl Formyl Piperidine Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase Inhibitors
Zhuoer Zhi, Wenting Zhang, Jingchun Yao, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 11, pp. 5783-5796
Closed Access | Times Cited: 18
Novel Reversible-Binding PET Ligands for Imaging Monoacylglycerol Lipase Based on the Piperazinyl Azetidine Scaffold
Jian Rong, Wakana Mori, Xiaotian Xia, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 19, pp. 14283-14298
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top